166 related articles for article (PubMed ID: 32932171)
1. Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.
Yeh CF; Ho CY; Chin YC; Shu CH; Chao YT; Lan MY
Oral Oncol; 2020 Nov; 110():104990. PubMed ID: 32932171
[TBL] [Abstract][Full Text] [Related]
2. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Zhou GQ; Ren XY; Mao YP; Chen L; Sun Y; Liu LZ; Li L; Lin AH; Mai HQ; Ma J
Sci Rep; 2016 Mar; 6():22326. PubMed ID: 26928265
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate analysis of prognostic makers in patients with nasopharyngeal carcinoma intreatment of radiotherapy combined with induction chemotherapy].
Liu J; Li S; Wang Y; Shi Y; Zhu L; Wu C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):937-40. PubMed ID: 26596014
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: A meta-analysis and systematic review.
Yang H; Wang K; Liang Z; Guo S; Zhang P; Xu Y; Zhou H
Clin Otolaryngol; 2020 Mar; 45(2):167-176. PubMed ID: 31573757
[TBL] [Abstract][Full Text] [Related]
7. Secondary Squamous Cell Carcinoma of the Oral Cavity after Nasopharyngeal Carcinoma.
Dai L; Fang Q; Li P; Wu J; Zhang X
Cancer Res Treat; 2020 Jan; 52(1):109-116. PubMed ID: 31163959
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
[TBL] [Abstract][Full Text] [Related]
9. [Effect of pretreatment serum LDH and ALP levels on the prognosis of patients with nasopharyngeal carcinoma].
Zhou JY; Chen T; Li W; Ye K; Wei ZB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1069-1073. PubMed ID: 29798242
[No Abstract] [Full Text] [Related]
10. Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis.
Zhai C; Gu K; Zhai X; Wang J; Zhang J
Clin Lab; 2017 Nov; 63(11):1777-1785. PubMed ID: 29226643
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
[TBL] [Abstract][Full Text] [Related]
13. Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.
Wang Y; Chen G
Medicine (Baltimore); 2017 Apr; 96(17):e6692. PubMed ID: 28445271
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases.
Wei Z; Zeng X; Xu J; Duan X; Yang J; Xie Y
Head Neck; 2014 Jan; 36(1):71-6. PubMed ID: 23728904
[TBL] [Abstract][Full Text] [Related]
15. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment.
Tian YM; Zeng L; Wang FH; Liu S; Guan Y; Lu TX; Han F
Radiat Oncol; 2013 Nov; 8():272. PubMed ID: 24252126
[TBL] [Abstract][Full Text] [Related]
17. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer.
Zhang W; Chen Y; Zhou G; Liu X; Chen L; Tang L; Mao Y; Sun Y; Ma J
Medicine (Baltimore); 2015 Sep; 94(37):e1505. PubMed ID: 26376394
[TBL] [Abstract][Full Text] [Related]
19. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
20. Staging of T2 and T3 nasopharyngeal carcinoma: Proposed modifications for improving the current AJCC staging system.
Cui C; Li H; Ma H; Dong A; Xie F; Liang S; Li L; Zhou J; Xie C; Yan Y; Liu L
Cancer Med; 2020 Oct; 9(20):7572-7579. PubMed ID: 32871059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
